Notice: This company has been marked as potentially delisted and may not be actively trading. Akers Biosciences (AKER) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends AKER vs. ABIO, VNRX, OCX, ICCC, ORKA, AWH, TRIB, VRAX, CDIO, and BMRAShould you be buying Akers Biosciences stock or one of its competitors? The main competitors of Akers Biosciences include ARCA biopharma (ABIO), VolitionRx (VNRX), OncoCyte (OCX), ImmuCell (ICCC), Oruka Therapeutics (ORKA), Aspira Women's Health (AWH), Trinity Biotech (TRIB), Virax Biolabs Group (VRAX), Cardio Diagnostics (CDIO), and Biomerica (BMRA). These companies are all part of the "medical" sector. Akers Biosciences vs. ARCA biopharma VolitionRx OncoCyte ImmuCell Oruka Therapeutics Aspira Women's Health Trinity Biotech Virax Biolabs Group Cardio Diagnostics Biomerica ARCA biopharma (NASDAQ:ABIO) and Akers Biosciences (NASDAQ:AKER) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends, profitability and community ranking. Do institutionals & insiders have more ownership in ABIO or AKER? 56.4% of ARCA biopharma shares are held by institutional investors. Comparatively, 5.5% of Akers Biosciences shares are held by institutional investors. 30.9% of ARCA biopharma shares are held by company insiders. Comparatively, 0.3% of Akers Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor ABIO or AKER? Akers Biosciences received 184 more outperform votes than ARCA biopharma when rated by MarketBeat users. Likewise, 72.92% of users gave Akers Biosciences an outperform vote while only 40.33% of users gave ARCA biopharma an outperform vote. CompanyUnderperformOutperformARCA biopharmaOutperform Votes12340.33% Underperform Votes18259.67% Akers BiosciencesOutperform Votes30772.92% Underperform Votes11427.08% Which has stronger valuation and earnings, ABIO or AKER? Akers Biosciences has higher revenue and earnings than ARCA biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioARCA biopharmaN/AN/A-$5.34M-$0.42N/AAkers Biosciences$1.58M14.33-$3.89MN/AN/A Is ABIO or AKER more profitable? ARCA biopharma's return on equity of -20.18% beat Akers Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets ARCA biopharmaN/A -20.18% -19.51% Akers Biosciences N/A -87.42%-73.31% Does the media prefer ABIO or AKER? In the previous week, ARCA biopharma's average media sentiment score of 0.13 beat Akers Biosciences' score of 0.00 indicating that ARCA biopharma is being referred to more favorably in the media. Company Overall Sentiment ARCA biopharma Neutral Akers Biosciences Neutral Which has more risk and volatility, ABIO or AKER? ARCA biopharma has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Akers Biosciences has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. SummaryARCA biopharma beats Akers Biosciences on 6 of the 10 factors compared between the two stocks. Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Get Akers Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKER and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKER vs. The Competition Export to ExcelMetricAkers BiosciencesDiagnostic Substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.65M$2.24B$5.11B$8.84BDividend YieldN/A0.75%5.05%4.07%P/E RatioN/A5.50108.8915.88Price / Sales14.3341.711,233.2287.15Price / CashN/A14.8239.9336.27Price / Book0.253.106.946.36Net Income-$3.89M$29.98M$119.18M$226.00M Akers Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKERAkers BiosciencesN/A$1.36+10.6%N/A+281.7%$22.65M$1.58M0.004ABIOARCA biopharmaN/AN/AN/AN/A$34.82MN/A-5.716Gap DownVNRXVolitionRx1.4741 of 5 stars$0.81flat$2.50+208.3%+10.9%$75.16M$770,000.00-2.2580Analyst ForecastOCXOncoCyte1.4424 of 5 stars$2.67-2.9%$4.42+65.4%-32.8%$44.94M$1.50M0.00120Analyst ForecastICCCImmuCell0.51 of 5 stars$3.66+1.7%N/A-22.1%$32.61M$17.47M-7.2075ORKAOruka Therapeutics3.7269 of 5 stars$20.50-7.7%$43.17+110.6%N/A$24.81MN/A-3.55N/AAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeAWHAspira Women's Health1.6805 of 5 stars$0.75+2.7%$4.40+488.4%-78.5%$12.01M$9.15M-0.62110Analyst ForecastTRIBTrinity Biotech1.8451 of 5 stars$1.30flatN/A-33.5%$9.91M$56.83M-0.58480VRAXVirax Biolabs Group0.2701 of 5 stars$1.94+3.2%N/A-24.8%$6.27M$160,000.000.005CDIOCardio Diagnostics2.1339 of 5 stars$0.25flat$2.00+708.4%-89.0%$5.92M$20,000.000.007BMRABiomerica0.2099 of 5 stars$0.34+3.1%N/A-64.4%$5.67M$5.41M-0.8860News CoverageGap Down Related Companies and Tools Related Companies ARCA biopharma Alternatives VolitionRx Alternatives OncoCyte Alternatives ImmuCell Alternatives Oruka Therapeutics Alternatives Aspira Women's Health Alternatives Trinity Biotech Alternatives Virax Biolabs Group Alternatives Cardio Diagnostics Alternatives Biomerica Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AKER) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akers Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
